PEOPLE - Carrington Laboratories announces retirement:
This article was originally published in Clinica
Dr David Shand is to retire as Carrington Laboratories' vice-president of research and development at the end of September. His interim replacement will be Dr Robert Fildes, currently a board member of the US pharmaceutical and medical device company.
You may also be interested in...
The latest figures from China's National Health Commission show infections of the new Wuhan coronavirus are continuing to pile up, spreading to more cities in the country and abroad as travel for the Lunar New Year festival goes into high gear. Meanwhile, the Chinese government maintains that the situation is “preventable and controllable.”
CDER Office of New Drugs changes its organization including establishing Office of Nonprescription Drugs and splitting the office into Division of Nonprescription Drug Products I and DNDP II. A Division of Regulatory Operations for Nonprescription Drugs will be comprised of regulatory staff from the ONPD divisions and will report to OND’s regulatory office. Non-clinical ONPD staff will report to the office director.